– First genetics testing company to sit on Forum
–
– Genetics perspective on committee will
accelerate healthcare quality standards aligning with medical and
technological advancements –
SAN
FRANCISCO, Sept. 27, 2022 /PRNewswire/ -- Invitae
(NYSE: NVTA), a leading medical genetics company, today announced
the company has received a three-year appointment to a National
Quality Forum (NQF) committee that provides input on
recommendations for quality standards that impact how healthcare is
delivered. Invitae is the first genetics testing company to join
the Measure Applications Partnership (MAP) Clinician workgroup
committee, representing a critical step in making genetics the
standard of care in mainstream medicine and potentially improving
healthcare for billions.
The MAP Clinician workgroup is a multi-stakeholder partnership
with organizations such as health plans and provider organizations
tasked with providing recommendations to the U.S. Department of
Health and Human Services on the selection and removal of
performance measures for federal public reporting,
performance-based payment and other health programs.
"The selection of Invitae to the MAP Clinician workgroup
indicates the National Quality Forum is prioritizing genomics for
their work in setting standards for quality healthcare. I am glad
to see NQF playing an active role to help incentivize this progress
of medicine and applaud their choice of Invitae. I look forward to
Invitae's contributions in this partnership," said Christine Cassel, MD, former NQF president and
CEO and former planning dean for Kaiser Permanente's School of
Medicine.
The MAP Clinician workgroup plays an important role for NQF's
evaluation and endorsement process for implementation of
standardized healthcare performance measures. Both public and
private payers use measures for a variety of accountability
purposes, including public reporting and performance-based payment
programs. Measures are an essential part of making the quality and
cost of healthcare more transparent to all, which is important for
those who receive care or make care decisions for loved ones. Use
of standardized healthcare performance measures allows for
comparison across clinicians, hospitals, health plans and other
providers.
"We believe healthcare quality, equity and patient safety cannot
be addressed without the recognition that genetics plays a critical
role. With this consideration, quality standards can help providers
and health plans keep up with the evidence, clinical guidelines and
advancement of medicine," said Chantelle
Schenning, PhD, MHA, head of healthcare transformation at
Invitae. "NQF's decision to invite our voice to represent the
genetics perspective and expertise creates a more balanced, diverse
stakeholder group that better aligns with advancements in clinical
care seen in the outpatient setting today."
Each year, millions of people are screened for or diagnosed with
diseases for which their genetic information can be clinically
actionable for them and their families. As genetic information
becomes increasingly important in driving healthcare
decision-making and outcomes, quality standards should reflect and
encourage the relevant use of genetics in clinical practice to help
treat and prevent disease. If incorporated appropriately, the
inclusion of genetics in quality measures could reduce (rather than
widen) existing disparities in patient outcomes in cancer,
cardiovascular disease, pediatrics and many others.
About the National Quality Forum
The National Quality
Forum (NQF) works with members of the healthcare community to drive
measurable health improvements together. NQF is a not-for-profit,
membership-based organization that gives all healthcare
stakeholders a voice in advancing quality measures and improvement
strategies that lead to better outcomes and greater value. Learn
more at www.qualityforum.org.
About Invitae
Invitae Corporation (NYSE: NVTA) is a
leading medical genetics company, whose mission is to bring
comprehensive genetic information into mainstream medicine to
improve healthcare for billions of people. Invitae's goal is to
aggregate the world's genetic tests into a single service with
higher quality, faster turnaround time and lower prices. For more
information, visit the company's website at invitae.com.
Safe Harbor Statement
This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, including statements
relating to the company's beliefs regarding its appointment to the
NQF committee, including that it will accelerate healthcare quality
standards aligning with medical and technological advancements and
that it represents a critical step in making genetics the standard
of care in mainstream medicine and potentially improving healthcare
for billions; and the company's belief that the inclusion of
genetics in quality measures could reduce existing disparities in
patient outcomes in many diseases. Forward-looking statements are
subject to risks and uncertainties that could cause actual results
to differ materially, and reported results should not be considered
as an indication of future performance. These risks and
uncertainties include, but are not limited to: the company's
history of losses; the company's ability to compete; the company's
failure to manage growth effectively; the company's need to scale
its infrastructure in advance of demand for its tests and to
increase demand for its tests; the company's ability to use rapidly
changing genetic data to interpret test results accurately and
consistently; security breaches, loss of data and other
disruptions; laws and regulations applicable to the company's
business; and the other risks set forth in the company's filings
with the Securities and Exchange Commission, including the risks
set forth in the company's Quarterly Report on Form 10-Q for the
quarter ended June 30, 2022. These
forward-looking statements speak only as of the date hereof, and
Invitae Corporation disclaims any obligation to update these
forward-looking statements.
Contact:
Renee Kelley
pr@invitae.com
(628) 213-3283
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invitae-appointed-to-national-quality-forum-committee-on-quality-standards-for-healthcare-301633447.html
SOURCE Invitae Corporation